TIVC RSI Chart
Last 7 days
-6%
Last 30 days
-58.0%
Last 90 days
-62.1%
Trailing 12 Months
-96.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 1.1M | 0 | 0 | 0 |
2023 | 1.8M | 1.4M | 1.2M | 1.2M |
2022 | 1.4M | 1.6M | 1.7M | 1.8M |
2021 | 959.3K | 1.1M | 1.2M | 1.3M |
2020 | 0 | 0 | 0 | 860.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 12, 2024 | bambach kimberly ann | acquired | - | - | 7,500 | interim cfo |
May 16, 2022 | drexler karen | sold | - | - | -15,111 | - |
Nov 12, 2021 | ernst jennifer | acquired | - | - | 28,377 | chief executive officer |
Which funds bought or sold TIVC recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | sold off | -100 | -90.00 | - | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 161 | 3,452 | 7,695 | -% |
May 13, 2024 | GEODE CAPITAL MANAGEMENT, LLC | added | 15.24 | -4,647 | 15,967 | -% |
May 13, 2024 | UBS Group AG | sold off | -100 | -391 | - | -% |
May 10, 2024 | VANGUARD GROUP INC | unchanged | - | -26,390 | 59,976 | -% |
May 10, 2024 | OSAIC HOLDINGS, INC. | unchanged | - | -80.00 | 182 | -% |
May 10, 2024 | WELLS FARGO & COMPANY/MN | unchanged | - | -6.00 | 14.00 | -% |
May 01, 2024 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | sold off | - | - | - | -% |
Aug 14, 2023 | One68 Global Capital, LLC | unchanged | - | -853 | 2,023 | 0.01% |
Unveiling Tivic Health Systems, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Tivic Health Systems, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
Tivic Health Systems, Inc. News
Income Statement (Quarterly) | ||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
Revenue | -6.4% | 334,000 | 357,000 | 282,000 | 161,000 | 376,000 | 407,500 | 477,000 | 528,000 | 428,000 | 408,500 | 389,000 | 277,000 | 268,000 | 323,000 | - |
Cost Of Revenue | -52.6% | 167,000 | 352,000 | 174,000 | 100,000 | 263,000 | 365,500 | 414,000 | 403,000 | 358,000 | - | 390,500 | 303,000 | 301,000 | 301,000 | - |
Gross Profit | 3240.0% | 167,000 | 5,000 | 108,000 | 61,000 | 113,000 | 42,000 | 63,000 | 125,000 | 70,000 | - | -1,500 | -26,000 | -33,000 | 22,000 | - |
Operating Expenses | -26.7% | 1,648,000 | 2,249,000 | 1,868,000 | 2,186,000 | 2,229,000 | 2,297,500 | 2,647,000 | 3,143,000 | 2,311,000 | - | 2,290,500 | 1,203,000 | 1,022,000 | 1,079,000 | - |
S&GA Expenses | -31.3% | 505,000 | 735,000 | 480,000 | 452,000 | 458,000 | 498,500 | 487,000 | 1,125,000 | 684,000 | - | 692,000 | 450,000 | 345,000 | 300,000 | - |
R&D Expenses | -28.9% | 256,000 | 360,000 | 337,000 | 468,000 | 490,000 | 434,000 | 399,000 | 497,000 | 401,000 | - | 313,000 | 175,000 | 192,000 | 198,000 | - |
EBITDA Margin | -3.7% | -7.26 | -7.00 | -8.22 | -7.09 | -5.64 | -5.48 | -5.30 | -6.41 | -6.77 | -7.14 | -7.81 | -2.77 | -3.03 | -3.34 | -3.73 |
Interest Expenses | - | - | - | - | - | - | 500 | 1,000 | - | 1,000 | - | -652,000 | -1,171,000 | 223,000 | 274,000 | - |
Earnings Before Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1,356,000 | - |
EBT Margin | -3.7% | -7.27 | -7.01 | -8.23 | -7.10 | -5.64 | -5.49 | -4.93 | -5.28 | -5.70 | -6.18 | -6.76 | -3.14 | -3.44 | -3.79 | -4.23 |
Net Income | 34.0% | -1,481,000 | -2,243,500 | -1,760,000 | -2,125,000 | -2,116,000 | -2,275,000 | -2,584,000 | -3,018,000 | -2,240,000 | - | -3,724,000 | -2,320,000 | -1,094,000 | -1,356,000 | - |
Net Income Margin | 4.3% | -6.71 | -7.01 | -6.75 | -6.40 | -5.59 | -5.50 | -4.93 | -5.29 | -5.70 | -6.18 | -6.76 | -3.14 | -3.44 | -3.79 | -4.23 |
Free Cashflow | 6.1% | -1,700,000 | -1,811,000 | -1,834,000 | -2,490,000 | -2,494,000 | -2,219,000 | -2,805,000 | -1,732,000 | -2,174,000 | - | - | - | - | - | - |
Balance Sheet | ||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2020Q4 |
Assets | -36.3% | 3,286 | 5,157 | 7,007 | 4,596 | 7,101 | 5,875 | 8,208 | 11,026 | 12,694 | 15,036 | 1,531 |
Current Assets | -39.2% | 2,827 | 4,652 | 6,455 | 4,000 | 6,482 | 5,306 | 7,594 | 10,372 | 11,998 | 14,289 | 1,497 |
Cash Equivalents | -50.9% | 1,668 | 3,400 | 5,200 | 2,659 | 5,200 | 3,517 | 6,328 | 9,049 | 10,801 | 12,975 | 1,044 |
Inventory | 2.4% | 774 | 756 | 928 | 988 | 943 | 863 | 761 | 833 | 447 | 429 | 241 |
Net PPE | -0.8% | 121 | 122 | 124 | 124 | 104 | 12.00 | 15.00 | 13.00 | 16.00 | 11.00 | 19.00 |
Liabilities | -28.2% | 1,133 | 1,577 | 1,242 | 1,435 | 1,896 | 2,245 | 2,436 | 2,839 | 1,601 | 1,764 | 2,708 |
Current Liabilities | -29.2% | 992 | 1,401 | 1,000 | 1,160 | 1,573 | 1,878 | 2,023 | 2,378 | 1,097 | 1,219 | 1,275 |
Shareholder's Equity | -39.9% | 2,153 | 3,580 | 5,765 | 3,161 | 5,205 | 3,630 | 5,772 | 8,187 | 11,093 | 13,272 | - |
Retained Earnings | -4.0% | -39,400 | -37,886 | -35,600 | -33,900 | -31,800 | -29,642 | -27,400 | -24,804 | -21,800 | -19,546 | -11,052 |
Additional Paid-In Capital | 0.1% | 41,520 | 41,466 | 41,408 | 37,041 | 36,960 | 33,272 | 33,159 | 32,990 | 32,878 | 32,817 | 9,874 |
Shares Outstanding | 0% | 1,466 | 1,466 | 1,466 | 297 | 297 | 97.00 | 97.00 | 96.00 | 97.00 | 97.00 | 23.00 |
Float | - | - | - | - | 3,000 | - | - | - | 13,000 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
Cashflow From Operations | 6.1% | -1,700 | -1,811 | -1,834 | -2,466 | -2,400 | -2,219 | -2,800 | -1,732 | -2,168 | - | -2,760 | -1,644 | -543 | -665 | - |
Share Based Compensation | -6.9% | 54.00 | 58.00 | 48.00 | 81.00 | 84.00 | 112 | 113 | 112 | 61.00 | - | 16.00 | 23.00 | 8.00 | 10.00 | - |
Cashflow From Investing | - | - | - | - | -24.00 | -94.00 | - | -5.00 | - | -6.00 | - | - | - | - | - | - |
Cashflow From Financing | -Infinity% | -61.00 | - | 4,381 | -44.00 | 4,170 | -584 | 56.00 | - | - | - | 14,887 | 869 | 1,566 | 221 | - |
Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenue | $ 334 | $ 376 |
Cost of sales | 167 | 263 |
Gross profit | 167 | 113 |
Operating expenses: | ||
Research and development | 256 | 490 |
Sales and marketing | 505 | 458 |
General and administrative | 887 | 1,281 |
Total operating expenses | 1,648 | 2,229 |
Loss from operations | (1,481) | (2,116) |
Net loss | $ (1,481) | $ (2,116) |
Net loss per share - basic | $ (1.01) | $ (10.52) |
Net loss per share - diluted | $ (1.01) | $ (10.52) |
Weighted-average number of shares - basic | 1,467,740 | 201,222 |
Weighted-average number of shares - diluted | 1,467,740 | 201,222 |
Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 1,668 | $ 3,395 |
Accounts receivable, net | 74 | 174 |
Inventory, net | 774 | 756 |
Deferred offering costs | 61 | 0 |
Prepaid expenses and other current assets | 250 | 327 |
Total current assets | 2,827 | 4,652 |
Property and equipment, net | 121 | 122 |
Right-of-use assets, operating lease | 304 | 349 |
Other assets | 34 | 34 |
Total assets | 3,286 | 5,157 |
Current liabilities | ||
Accounts payable | 547 | 713 |
Other accrued expenses | 265 | 495 |
Operating lease liability, current | 180 | 193 |
Total current liabilities | 992 | 1,401 |
Operating lease liability | 141 | 176 |
Total liabilities | 1,133 | 1,577 |
Commitments and contingencies (Note 6) | ||
Stockholders' equity | ||
Common stock, $0.0001 par value, 200,000,000 shares authorized; 1,473,592 and 1,466,092 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 0 | 0 |
Additional paid in capital | 41,520 | 41,466 |
Accumulated deficit | (39,367) | (37,886) |
Total stockholders' equity | 2,153 | 3,580 |
Total liabilities and stockholders' equity | $ 3,286 | $ 5,157 |